Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Discover the highest cash back credit card for all purchases and learn how to maximize your rewards effectively.
24,876 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
As markets enter the midyear phase of 2026, three proven compounders highlight why patient investing still works. App...
A single quarterly beat isn’t the whole story. Micron’s latest results point to a multi-decade growth thesis that goe...
A DXP Enterprises director sold nearly 7,000 shares in a single transaction. This article breaks down the details, ex...
A biotech stock can surge on hype, but smart investors dig into the data behind the rally. This guide breaks down how...
IREN stock fell sharply as investors reprice AI infrastructure bets after a month of steep declines. While the sector...
A mid-size fund reduced its TriMas stake by about $5 million after a strong run, but didn’t exit the position entirel...
A high-profile investor sends a pointed message about Whirlpool’s strategy. This article explains what the billionair...
A sharp February move put Remitly Global in the spotlight. This article breaks down the catalysts behind the rally, t...
AI breakthroughs are reshaping markets, and NVIDIA sits at the center. This article explains why nvidia could remain ...
Bitcoin traders grapple with a tightening macro backdrop as the Fed's liquidity cushion shrinks, signaling tighter fu...
Investors just got a fresh catalyst as Uber commits to autonomous progress. This article breaks down what Dara Khosro...